MAPT and Alzheimer disease: For instances several studies have examined in CSF the presence of biomarkers typically used for diagnosis of Alzheimer disease as amyloid β (Aβ), Tau and P-Tau [6,7], looking for a possible use to separate patients with iNPH from patients with other neurodegenerative disorders.